Vanguard Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.82M | Sell |
8,766,764
-1,543,689
| -15% | -$1.73M | ﹤0.01% | 2916 |
|
|
2025
Q1 | $8.15M | Sell |
10,310,453
-22,580
| -0.2% | -$17.8K | ﹤0.01% | 2960 |
|
|
2024
Q4 | $17M | Sell |
10,333,033
-71,090
| -0.7% | -$117K | ﹤0.01% | 2659 |
|
|
2024
Q3 | $36.4M | Sell |
10,404,123
-165,691
| -2% | -$580K | ﹤0.01% | 2315 |
|
|
2024
Q2 | $34.7M | Buy |
10,569,814
+658,807
| +7% | +$2.16M | ﹤0.01% | 2296 |
|
|
2024
Q1 | $72.7M | Buy |
9,911,007
+617,644
| +7% | +$4.53M | ﹤0.01% | 2015 |
|
|
2023
Q4 | $34.8M | Sell |
9,293,363
-1,614,988
| -15% | -$6.04M | ﹤0.01% | 2341 |
|
|
2023
Q3 | $23.1M | Sell |
10,908,351
-815,023
| -7% | -$1.73M | ﹤0.01% | 2491 |
|
|
2023
Q2 | $55.8M | Buy |
11,723,374
+762,427
| +7% | +$3.63M | ﹤0.01% | 2137 |
|
|
2023
Q1 | $62.5M | Buy |
10,960,947
+2,988,396
| +37% | +$17M | ﹤0.01% | 2067 |
|
|
2022
Q4 | $80.4M | Buy |
7,972,551
+157,571
| +2% | +$1.59M | ﹤0.01% | 1927 |
|
|
2022
Q3 | $175M | Buy |
7,814,980
+57,040
| +0.7% | +$1.28M | 0.01% | 1461 |
|
|
2022
Q2 | $192M | Buy |
7,757,940
+66,768
| +0.9% | +$1.65M | 0.01% | 1444 |
|
|
2022
Q1 | $298M | Buy |
7,691,172
+15,385
| +0.2% | +$596K | 0.01% | 1299 |
|
|
2021
Q4 | $449M | Buy |
7,675,787
+49,441
| +0.6% | +$2.89M | 0.01% | 1072 |
|
|
2021
Q3 | $452M | Buy |
7,626,346
+55,665
| +0.7% | +$3.3M | 0.01% | 1035 |
|
|
2021
Q2 | $657M | Buy |
7,570,681
+95,144
| +1% | +$8.26M | 0.02% | 825 |
|
|
2021
Q1 | $616M | Buy |
7,475,537
+696,950
| +10% | +$57.5M | 0.02% | 828 |
|
|
2020
Q4 | $616M | Buy |
6,778,587
+502,525
| +8% | +$45.7M | 0.02% | 778 |
|
|
2020
Q3 | $251M | Buy |
6,276,062
+1,177,511
| +23% | +$47.1M | 0.01% | 1128 |
|
|
2020
Q2 | $175M | Buy |
5,098,551
+1,847,929
| +57% | +$63.4M | 0.01% | 1351 |
|
|
2020
Q1 | $72.2M | Buy |
3,250,622
+125,853
| +4% | +$2.8M | ﹤0.01% | 1686 |
|
|
2019
Q4 | $61.2M | Buy |
3,124,769
+72,417
| +2% | +$1.42M | ﹤0.01% | 2007 |
|
|
2019
Q3 | $47.4M | Buy |
3,052,352
+324,362
| +12% | +$5.04M | ﹤0.01% | 2100 |
|
|
2019
Q2 | $55.4M | Buy |
2,727,990
+6,146
| +0.2% | +$125K | ﹤0.01% | 2048 |
|
|
2019
Q1 | $47.8M | Buy |
2,721,844
+179,854
| +7% | +$3.16M | ﹤0.01% | 2107 |
|
|
2018
Q4 | $32.6M | Buy |
2,541,990
+93,711
| +4% | +$1.2M | ﹤0.01% | 2230 |
|
|
2018
Q3 | $39.9M | Buy |
2,448,279
+275,828
| +13% | +$4.49M | ﹤0.01% | 2254 |
|
|
2018
Q2 | $24.6M | Buy |
2,172,451
+354,730
| +20% | +$4.02M | ﹤0.01% | 2475 |
|
|
2018
Q1 | $17.7M | Buy |
1,817,721
+358,585
| +25% | +$3.5M | ﹤0.01% | 2551 |
|
|
2017
Q4 | $8.92M | Buy |
1,459,136
+176,143
| +14% | +$1.08M | ﹤0.01% | 2874 |
|
|
2017
Q3 | $5.08M | Buy |
1,282,993
+18,712
| +1% | +$74.1K | ﹤0.01% | 3111 |
|
|
2017
Q2 | $4.1M | Buy |
1,264,281
+108,602
| +9% | +$352K | ﹤0.01% | 3158 |
|
|
2017
Q1 | $5.26M | Buy |
1,155,679
+523,684
| +83% | +$2.38M | ﹤0.01% | 3036 |
|
|
2016
Q4 | $1.59M | Sell |
631,995
-55,698
| -8% | -$140K | ﹤0.01% | 3437 |
|
|
2016
Q3 | $2.15M | Buy |
687,693
+30,120
| +5% | +$93.9K | ﹤0.01% | 3362 |
|
|
2016
Q2 | $1.12M | Buy |
657,573
+22,098
| +3% | +$37.6K | ﹤0.01% | 3577 |
|
|
2016
Q1 | $1.14M | Buy |
635,475
+220,232
| +53% | +$396K | ﹤0.01% | 3560 |
|
|
2015
Q4 | $1.4M | Buy |
415,243
+46,264
| +13% | +$156K | ﹤0.01% | 3521 |
|
|
2015
Q3 | $1.97M | Buy |
368,979
+31,741
| +9% | +$169K | ﹤0.01% | 3384 |
|
|
2015
Q2 | $2.18M | Buy |
337,238
+156,600
| +87% | +$1.01M | ﹤0.01% | 3378 |
|
|
2015
Q1 | $883K | Buy |
180,638
+8,700
| +5% | +$42.5K | ﹤0.01% | 3668 |
|
|
2014
Q4 | $865K | Hold |
171,938
| – | – | ﹤0.01% | 3575 |
|
|
2014
Q3 | $884K | Buy |
171,938
+23,332
| +16% | +$120K | ﹤0.01% | 3548 |
|
|
2014
Q2 | $938K | Hold |
148,606
| – | – | ﹤0.01% | 3504 |
|
|
2014
Q1 | $1.45M | Buy |
148,606
+130,080
| +702% | +$1.27M | ﹤0.01% | 3340 |
|
|
2013
Q4 | $116K | Buy |
+18,526
| New | +$116K | ﹤0.01% | 3819 |
|